The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.15
Bid: 140.90
Ask: 141.00
Change: -2.75 (-1.91%)
Spread: 0.10 (0.071%)
Open: 142.15
High: 143.95
Low: 140.90
Prev. Close: 143.90
CNA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

14 Apr 2020 07:00

RNS Number : 4694J
Centrica PLC
14 April 2020
 

14 April 2020

Centrica plc

("the Company")

 

Group Chief Executive appointment

 

Centrica plc is pleased to announce the appointment of Chris O'Shea as Group Chief Executive on a permanent basis with immediate effect.

Scott Wheway, Centrica Chairman, said:

"In the last few weeks since my appointment I have completed a review of both the internal and external candidates for this role and have come to the conclusion that Chris is comprehensively the best candidate for Centrica. I'm delighted to appoint him to the role on a permanent basis.

"The Board is confident that he is the right leader to navigate Centrica through and beyond the present Covid-19 crisis focusing on the welfare of our colleagues and customers, the financial resilience of the company and the agility to move quickly when we emerge from these unprecedented circumstances."

Chris O'Shea said:

"It is a huge honour to be appointed to lead Centrica. The company has a long history of serving customers, strong market positions and over recent years has built the capabilities to help our customers transition to a low carbon future. I'm very proud of how the Centrica team is looking after our customers and our colleagues through the Covid-19 crisis.

"Beyond this present emergency our focus will be on creating value for all of our stakeholders through delivering growth in our customer facing businesses, the structural simplification of the Group, and building on the undoubted strengths and capabilities we have in our people and our businesses today."

Notes to Editors

Chris O'Shea was appointed to the Centrica Board as Group Chief Financial Officer on 1 November 2018 and became interim CEO with effect from 17 March 2020.

Chris O'Shea's remuneration package will consist of a basic salary and variable incentive arrangements which are in line with Centrica's current remuneration policy and practice. The key changes to his current arrangements are a base salary of £775,000 and a reduction from 15% to 10% pension contribution.

In recognition of the current crisis, Chris has already taken a voluntary reduction in salary of £100,000. This reduction will continue until the company resumes normal operations.

The company has commenced a search for a new Chief Financial Officer, and an announcement will be made in due course.

The information communicated in this announcement is inside information.

 

ENDS

 

Enquiries:

 

Investors/analysts 01753 494900 ir@centrica.com

 

Media 01784 843000 media@centrica.com

 

 

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654Legal Entity Identifier number: E26EDV109X6EEPBKVH76ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAIJMMTMTMBTFM
Date   Source Headline
27th Apr 20236:00 pmRNSTransaction in Own Shares
27th Apr 20235:30 pmRNSHolding(s) in Company
27th Apr 20235:00 pmRNSHolding(s) in Company
27th Apr 202310:00 amRNSHolding(s) in Company
26th Apr 20236:15 pmRNSTransaction in Own Shares
25th Apr 20236:15 pmRNSTransaction in Own Shares
25th Apr 20234:30 pmRNSDirector/PDMR Shareholding
24th Apr 20236:25 pmRNSTransaction in Own Shares
21st Apr 20236:15 pmRNSTransaction in Own Shares
21st Apr 20232:15 pmRNSHolding(s) in Company
20th Apr 20236:15 pmRNSTransaction in Own Shares
19th Apr 20236:16 pmRNSTransaction in Own Shares
18th Apr 20236:10 pmRNSTransaction in Own Shares
17th Apr 20236:25 pmRNSTransaction in Own Shares
17th Apr 20235:00 pmRNSHolding(s) in Company
14th Apr 20236:00 pmRNSTransaction in Own Shares
13th Apr 20236:00 pmRNSTransaction in Own Shares
13th Apr 20234:45 pmRNSHolding(s) in Company
12th Apr 20236:25 pmRNSTransaction in Own Shares
12th Apr 20235:00 pmRNSHolding(s) in Company
12th Apr 20232:45 pmRNSDirector/PDMR Shareholding
11th Apr 20236:25 pmRNSTransaction in Own Shares
6th Apr 20236:30 pmRNSTransaction in Own Shares
6th Apr 20234:30 pmRNSHolding(s) in Company
5th Apr 20236:30 pmRNSTransaction in Own Shares
5th Apr 20232:15 pmRNSHolding(s) in Company
5th Apr 20232:00 pmRNSTransfer of Treasury Shares
5th Apr 20237:00 amRNSCommencement of Share Buy-Back Programme
3rd Apr 202310:00 amRNSTotal Voting Rights
30th Mar 20235:30 pmRNSDirector/PDMR Shareholding
29th Mar 20236:25 pmRNSTransaction in Own Shares
28th Mar 20236:25 pmRNSTransaction in Own Shares
27th Mar 20236:20 pmRNSTransaction in Own Shares
27th Mar 202312:30 pmRNSDirector/PDMR Shareholding
24th Mar 20236:15 pmRNSTransaction in Own Shares
24th Mar 20235:00 pmRNSHolding(s) in Company
24th Mar 202310:00 amRNSHolding(s) in Company
23rd Mar 20236:00 pmRNSTransaction in Own Shares
22nd Mar 20236:10 pmRNSTransaction in Own Shares
22nd Mar 20233:30 pmRNSDirector/PDMR Shareholding
22nd Mar 202311:19 amRNSAnnual Financial Report 2022
21st Mar 20236:10 pmRNSTransaction in Own Shares
20th Mar 20236:20 pmRNSTransaction in Own Shares
20th Mar 20235:20 pmRNSHolding(s) in Company
17th Mar 20236:15 pmRNSTransaction in Own Shares
16th Mar 20236:00 pmRNSTransaction in Own Shares
16th Mar 20235:00 pmRNSHolding(s) in Company
15th Mar 20236:25 pmRNSTransaction in Own Shares
15th Mar 20234:20 pmRNSHolding(s) in Company
15th Mar 20239:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.